← Leaderboards
Jorge A Dipaola
Washington University
$12,637,585
Attributed
$17,250,170
Total exposure
21
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,613,394 · 22
By mechanism
R01$6,688,800 · 3
P01$6,308,064 · 5
R33$1,862,433 · 1
T32$1,595,407 · 2
R61$1,380,019 · 1
RC1$999,563 · 1
Top collaborators
- Keith B Neeves10 shared
- Aaron L Fogelson5 shared
- Karin Leiderman5 shared
- Steven Herbert Abman4 shared
- Joshua B Rubin3 shared
- Nanette Regina Boyle1 shared
- Arthur Gutierrez-Hartmann1 shared
- James H. Morrissey1 shared
Most similar at Washington University
Same institution · by research overlap
- Jie Zheng$5,200,344
- Stuart A Kornfeld$19,398,204
- J Evan Sadler$26,812,449
- Jeffrey J Atkinson$2,152,708
- Brooke Sadler$337,602
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeHemorrhageGeneticGenesAffectVon Willebrand DiseaseVon Willebrand FactorMolecularBlood PlateletsGenomicsThrombosisMutationBaseVariantBiologyPlayComplexPatternInsightUnited States National Institutes Of HealthResponseTranscriptome SequencingDiagnosisCandidate Disease Gene
Grant awards (57)
The New Zimmerman Program for the Genetics and Biology of von Willebrand Factor and von Willebrand Disease$2,363,224
P01 · FY2025 · HL · contact PI
Genomic regulation of VWF levels in health and disease$337,604
P01 · FY2025 · HL · contact PI
Administrative Core$337,604
P01 · FY2025 · HL · contact PI
Pediatric Training Program Hematology and Oncology$155,642
T32 · FY2025 · CA
Pediatric Training Program Hematology and Oncology$211,189
T32 · FY2024 · CA
Genomics of Megakaryocyte and Platelet Biology$561,860
R01 · FY2023 · HL · contact PI
Core B: Genomics and Bioinformatics Core$342,984
P01 · FY2023 · HL · contact PI
Pediatric Training Program Hematology and Oncology$204,238
T32 · FY2023 · CA
A SYSTEMS BIOLOGY APPROACH TO IDENTIFYING THE MECHANISMS OF SEX HORMONE INDUCED THROMBOEMBOLISM IN PRE-MENOPAUSAL WOMEN$608,280
R33 · FY2022 · HL
Genomics of Megakaryocyte and Platelet Biology$561,860
R01 · FY2022 · HL · contact PI
Core B: Genomics and Bioinformatics Core$308,797
P01 · FY2022 · HL · contact PI
Pediatric Training Program Hematology and Oncology$190,259
T32 · FY2022 · CA
A SYSTEMS BIOLOGY APPROACH TO IDENTIFYING THE MECHANISMS OF SEX HORMONE INDUCED THROMBOEMBOLISM IN PRE-MENOPAUSAL WOMEN$608,149
R33 · FY2021 · HL
Genomics of Megakaryocyte and Platelet Biology$561,860
R01 · FY2021 · HL · contact PI
Core B: Genomics and Bioinformatics Core$344,009
P01 · FY2021 · HL · contact PI
A SYSTEMS BIOLOGY APPROACH TO IDENTIFYING THE MECHANISMS OF SEX HORMONE INDUCED THROMBOEMBOLISM IN PRE-MENOPAUSAL WOMEN$646,004
R33 · FY2020 · HL
Genomics of Megakaryocyte and Platelet Biology$589,972
R01 · FY2020 · HL · contact PI
Core B: Genomics and Bioinformatics Core$346,749
P01 · FY2020 · HL · contact PI
A SYSTEMS BIOLOGY APPROACH TO IDENTIFYING THE MECHANISMS OF SEX HORMONE INDUCED THROMBOEMBOLISM IN PRE-MENOPAUSAL WOMEN$710,913
R61 · FY2019 · HL
Core B: Genomics and Bioinformatics Core$375,151
P01 · FY2019 · HL · contact PI
Medical Scientist Training Program$834,079
T32 · FY2018 · GM
A systems biology approach to identifying the mechanisms of sex hormone induced thromboembolism in pre-menopausal women$669,106
R61 · FY2018 · HL
A Systems Biology Approach to Predicting Bleeding in Hemophilia$572,678
R01 · FY2018 · HL
A Systems Biology Approach to Predicting Bleeding in Hemophilia$573,115
R01 · FY2017 · HL
A Systems Biology Approach to Predicting Bleeding in Hemophilia$570,499
R01 · FY2016 · HL
2016 Hemostasis Gordon Research Conference and Gordon Research Seminar$24,980
R13 · FY2016 · HL
A Systems Biology Approach to Predicting Bleeding in Hemophilia$576,982
R01 · FY2015 · HL
Pediatric Pulmonology and Hematology Research Training for Medical Students$1,281
T35 · FY2015 · HL
A Systems Biology Approach to Predicting Bleeding in Hemophilia$421,786
R01 · FY2014 · HL
Pediatric Pulmonology and Hematology Research Training for Medical Students$15,555
T35 · FY2014 · HL
Pediatric Pulmonology and Hematology Research Training for Medical Students$24,935
T35 · FY2013 · HL
Pediatric Pulmonology and Hematology Research Training for Medical Students$24,935
T35 · FY2012 · HL
Genetic Modifiers of von Willebrand Disease$344,250
R01 · FY2011 · HL · contact PI
Use of microfluidics in determining hemostatic phenotypes$499,564
RC1 · FY2010 · HL · contact PI
Genetic Modifiers of von Willebrand Disease$344,532
R01 · FY2010 · HL · contact PI
Use of microfluidics in determining hemostatic phenotypes$499,999
RC1 · FY2009 · HL · contact PI
Genetic Modifiers of von Willebrand Disease$345,656
R01 · FY2009 · HL · contact PI
THE MOLECULAR GENETIC PATHOLOGY OF TYPE 1 VWD$339,191
P01 · FY2009 · HL · contact PI
THE MOLECULAR GENETIC PATHOLOGY OF TYPE 1 VWD$345,313
P01 · FY2008 · HL · contact PI
Genetic Modifiers of von Willebrand Disease$331,875
R01 · FY2008 · HL · contact PI
Genetic Modifiers of von Willebrand Disease$331,875
R01 · FY2007 · HL · contact PI
THE MOLECULAR GENETIC PATHOLOGY OF TYPE 1 VWD$305,508
P01 · FY2007 · HL · contact PI
ROLE OF GENETIC MODIFIERS IN BLEEDING DISORDERS$13,298
M01 · FY2007 · RR · contact PI
THE MOLECULAR AND CLINICAL BIOLOGY OF VON WILLEBRAND DISEASE (VWD)$2,441
M01 · FY2007 · RR · contact PI
THE MOLECULAR GENETIC PATHOLOGY OF TYPE 1 VWD$281,819
P01 · FY2006 · HL · contact PI
THE MOLECULAR GENETIC PATHOLOGY OF TYPE 1 VWD$280,111
P01 · FY2005 · HL
Role of Platelet Integrin a2b1 in von Willebrand Disease$125,010
K23 · FY2005 · HL
ROLE OF THE PLATELET INTEGRIN ALPHA 2 BETA 1 IN VON WILLEBRAND DISEASE$14,568
M01 · FY2005 · RR
ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX IN SURGICAL PATIENTS$1,522
M01 · FY2005 · RR
Role of Platelet Integrin a2b1 in von Willebrand Disease$125,010
K23 · FY2004 · HL
Platelet Integrin Alpha2 Beta1 in von Willebrand Disease$16,191
M01 · FY2004 · RR
BDDrVIII IN THE TREATMENT OF PREVIOUSLY TREATED PATIENTS$5,060
M01 · FY2004 · RR
RECOMBINANT ANTIHEMOPHILIC FACTOR IN HEMOPHILIA A$4,723
M01 · FY2004 · RR
Antihemophilic Factor/von Willebrand Factor Complex$4,587
M01 · FY2004 · RR
Role of Platelet Integrin a2b1 in von Willebrand Disease$125,010
K23 · FY2003 · HL
Role of Platelet Integrin a2b1 in von Willebrand Disease$125,010
K23 · FY2002 · HL
Role of Platelet Integrin a2b1 in von Willebrand Disease$124,992
K23 · FY2001 · HL